Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Amgen Stock Falls After Pipeline Drug Report

Shares of Amgen Inc. fell more than 3 percent in premarket trading Monday after the Thousand Oaks biotech released disappointing data about a pipeline cancer drug.

Joint Venture to Create Life Science Campus in Thousand Oaks

A joint venture between Los Angeles-based HATCHspaces and Singerman Real Estate in Chicago plans to create the HATCHcampus, a collection of life science facilities.

Simulations Plus Collaboration to Research Joint Medications

Simulations Plus has partnered with an unnamed clinical-stage biotech company to develop a new delivery model using its GastroPlus software.

CBDfx Finds Marketing Partner for Hemp Products

CBDfx, a hemp-derived CBD company in Chatsworth, has partnered with Emerson Group, a brand marketing organization in Wayne, Pa., to place CBDfx products in retail stores around the country.

Preview: Investor Group Calls Itself 'Hope for MannKind'

Shareholders seek better marketing for Afrezza.

HemaCare Partners to Penetrate Chinese Market

HemaCare Corp., a provider of human blood and immune cells for medical therapies and research, has partnered with Vital River to distribute its product in the Chinese market.

Amgen to Pay $13.4 Billion for Psorasis Drug Otezla

Amgen Inc. on Monday announced it will acquire Otezla, a Celgene Corp. psoriasis drug, for $13.4 billion in cash.

Valley Pharmacy Owners Found Guilty of Health Care Fraud

Two Valley residents who ran a pharmacy were convicted Tuesday for running a $35 million fraud that billed Medicare for medicines that were never delivered.

Women’s Health Center Opens in Pacoima

Northeast Valley Health Corp. has opened a women’s health care clinic in Pacoima, as an extension of the company’s Pacoima Health Center.

Kaiser Unions Plan to Strike in October

Kaiser Permanente workers in California have voted to strike beginning in October, according to a statement from the Coalition of Kaiser Permanente Unions.

MannKind Posts Bigger Numbers in Second Quarter

MannKind Corp. met analyst expectations for earnings and fell just short on revenue in the second quarter.

MannKind Offers Predictive Technology to Afrezza Users

MannKind Corp. and One Drop have signed an agreement to integrate MannKind’s BluHale accessory device into the One Drop platform.

Sienna Biopharmaceuticals Explores 'Strategic Alternatives'

Sienna Biopharmaceuticals has retained Cowen as an independent financial advisor to explore “financial and strategic alternatives” to boost shareholder values.

Preview: Quick End for ImmunoCellular

ImmunoCellular Therapeutics Ltd. – once a promising public biotech company working on cancer therapies – abruptly terminated its operations late last year.

Hospital Signs Lease at Tarzana Medical Atrium

Providence Tarzana Medical Center has signed a 10-year lease for one-third of the space at the nearby Tarzana Medical Atrium.

Tease photo